Results of an RCT of the coalition’s ‘hot spotting’ approach resulted in some reevaluation.
About a month before COVID-19 began sweeping across the country, the results of an important study of a program — designed to address the needs of patients who are high utilizers of the healthcare system — were published in the New England Journal of Medicine. Sometimes called frequent fliers, these high utilizers tend to have multiple chronic conditions, make frequent visits to the emergency department and get admitted to the hospital often. They constitute about 5% of patients but account for about 50% of total costs, according to the federal Agency for Healthcare Research and Quality. “Hot spotting” programs, which would find ways to intervene before the high utilizers’ healthcare problems became so regular, serious and expensive, hold a lot of appeal and make common sense.
The NEJM study was supported by the Abdul Latif Jameel Poverty Action Lab (J-PAL), a research organization at the Massachusetts Institute of Technology whose founders shared the Nobel Memorial Prize in Economic Sciences in 2019. J-Pal has pioneered the use of randomized controlled trials (RCTs) to test the effectiveness of health, economic and social programs; its findings have upended prevailing beliefs more than once. The results from this particular study showed that a hot spotting program in Camden, New Jersey, that had been praised by Atul Gawande, M.D., among others, did not reduce hospital readmissions. Although hospital readmissions were 40% lower among the patients in the program, the decline was nearly the same among patients in the control group.
When the results were published in the Jan. 9, 2020, issue of the prestigious medical journal, Kathleen Noonan, CEO of the Camden Coalition of Healthcare Providers, the group running the program, told The New York Times, “We’re disappointed by the results.” Noonan added that treating such patients with effectivity “is very, very hard work.”
Now, more than a half a year later, Camden Coalition officials say they have made adjustments to their program as a result of the RCT. “The Camden Coalition adapted its care intervention throughout the RCT and continues to do so based on what we learned since then,” Noonan says. “We found early on that we need to focus on cultivating deeper partnerships with social service organizations and launching programs that look beyond healthcare to get at the root causes of poor health outcomes.”
Since 2003, when Jeffrey Brenner, M.D., founded the coalition, the staff has recognized that these patients need primary care, social services, housing, food and, in some cases, a lawyer. “During the course of the RCT, we started programs in response to the overwhelming need we saw on the ground for things like housing and legal support,” says Noonan, pointing to the 7-Day Pledge, a citywide program that aims to get patients a primary care appointment within seven days after they have been discharged.
Noonan summarized what coalition leaders and staff have learned about patients with high utilization patterns:
Implementing these solutions is difficult in a healthcare system built to provide episodic care in which emergency rooms or urgent care centers may do little more than “treat and street.” Instead, almost all these patients need seamlessly integrated care in which anyone with high needs can get treatment tailored to his or her specific health and social-service needs. Getting funding for this care is a barrier to developing systems for these patients because it costs more than usual care.
Other challenges loom, ones that are beyond the easy reach of the healthcare system, Noonan says. “We must acknowledge how the issues of racism, poverty and the disinvestment in many urban areas underlie our patients’ challenges,” she says. “Without major financial and political investments in addressing those issues, any intervention will have limited impact.”
Despite these hurdles, Noonan says the coalition will continue to apply lessons learned from the RCT.
“Our next steps are to continue to adapt and test programs that aim to reduce utilization of the health system (and) also to achieve our broader goals concerning quality of life for these patients, self-advocacy and other patient-identified goals.
“It’s clear that there is still so much to learn,” she notes. “We will, as we did all along, look to the data for additional insights and listen to our community and front-line staff in order to evolve our programs.”
Joseph Burns is an independent journalist in Massachusetts who writes about healthcare.
MHE Talks: Joe Gagnon and Don Rucker of 1upHealth Address How FHIR is Personalizing Healthcare
May 11th 2022This week welcomes Managed Healthcare Executive's 100th podcast episode featured on "Tuning In to the C-Suite" podcast! Guests on this episode are members of 1upHealth, CEO Joe Gagnon and Chief Strategy Officer, Don Rucker. The two were featured on the latest episode of "Tuning In to the C-Suite's" podcast series "MHE Talks: Improving Patient Access" to discuss the adoption of FHIR, or Fast Healthcare Interoperability Resource, in healthcare and how it’s not only simplifying healthcare through care quality, outcomes and costs, but how it’s providing further access to health data for patients and payers. The guests of the 100th episode also shared some strategies for payers and providers in using FHIR to implement and scale modern data, and more.
Read More
Welcome back to another episode of the returned MHE Talks: Improving Patient Access podcast. In this episode Briana Contreras, editor of Managed Healthcare Executive, spoke with Wes Gilson, senior director MR of Business Development at Siemens Healthineers. In the conversation, the two discussed why improving access to magnetic resonance imaging (MRI) is crucial to advancing health equity. Gilson addressed the barriers many face when accessing MRI services and its solutions from tackling the barriers specific to areas affected, alternative technologies, developing new innovations in MRI tech and more.
Read More
In this latest episode of the MHE Talks: Improving Patient Access series, Senior Editor Peter Wehrwein spoke with Dr. Christopher Crow, resident of Catalyst Health Network, a clinically integrated network of more than 1,000 primary care physicians throughout Texas. Peter and Dr. Crow discuss how his small-town roots and doctors there inspired his thinking about access issues; his experience with patient-centered medical homes and setting patient access as a priority; how Catalyst supports physicians in improving access; and the lack of Medicaid expansion in Texas and how that affects access there.
Read More
ICER Chief on Bempedoic Acid and Inclisiran: Don’t Repeat the PCSK9 Mistake
April 13th 2021In this new episode of MHE Talks: Improving Patient Access podcast, Steven D. Pearson, M.D., M.Sc., warns that high prices can squander an opportunity to bring innovative medications into clinical use.
Read More
A Seat at the Table? No. Equity Means Changing the Shape of the Table.
March 25th 2021Senior Editor Peter Wehrwein spoke with Vayong Moua, the Director of Racial and Health Equity Advocacy for Blue Cross and Blue Shield of Minnesota (BCBSMN), for this week's episode of the "MHE Talks: Improving Patient Access" podcast series. Wehrwein and Moua discussed healthcare equity issues, how they relate to access issues, the political determinants of health and killing of George Floyd.
Read More
Thomas P. Leist, MD, PhD, a neurologist and professor of Multiple Sclerosis at Jefferson University Hospitals, is the latest guest featured on MHE Talks: Improving Patient Access podcast. In this episode, Thomas spoke with Peter Wehrwein, senior editor of Managed Healthcare Executive, about accessing care amongst patients with MS through therapies, health insurance barriers, options of step therapy and more.
Read More